Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin.

info:eu-repo/semantics/publishedVersio

CHEMICAL COMPOSITION, ANTIOXIDANT AND ANTIMICROBIAL PROPERTIES OF THREE ESSENTIAL OILS FROM PORTUGUESE FLORA

The present work reports on the evaluation of chemical composition and antioxidant and antimicrobial activities of essential oils of three aromatic herbs, growing wild in the south of Portugal, used in traditional food preparations: Foeniculum vulgare, Mentha spicata and Rosmarinus officinalis. The principal components of essential oils were anethole (41.2%) for F. vulgare, carvone (41.1%) for M. spicata and myrcene (23.7%) for R. officinalis. Essential oils showed antioxidant activity either by DPPH radical scavenging method and system β- carotene/acid linoleic method. Antimicrobial activity of essential oils was observed against pathogenic bacteria and yeasts and food spoilage fungi. F.vulgare essential oil showed bacterial activity against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enteritidis, Staphylococcus aureus, Aspergillus niger and Fusarium oxysporum with MICs of 0.25-0.75mg/mL. M. spicata oil was active against E.coli, S.aureus, C.albicans, A. niger and F. oxysporum with MICs ranging between 0.25 and 0.75mg/mL. R. officinalis essential oil showed activity against E.coli and C.albicans with MICs of 0.5-1.0mg/mL. Having in account the important antioxidant and antimicrobial properties observed in present work, we consider that these essential oils might be useful on pharmaceutical and food industry as natural antibiotic and food preservativ

Off-label prescribing for allergic diseases in pre-school children

BACKGROUND: Several studies have demonstrated that medication is commonly used off-label in children with allergic diseases. The aim of this study was to characterise off-label use of prescriptions for allergic diseases in pre-school children from an allergology outpatient unit. METHODS: The clinical files of children aged ≤6 years seen in a reference allergology consultation with asthma, allergic rhinitis, and/or atopic eczema were reviewed. A total of 500 patients were consecutively observed from January to June 2012. The data collected included gender, age, diagnosis, and prescriptions with the respective daily dosage. RESULTS: A total of 1224 prescriptions were registered. The most prescribed medications were oral antihistamines (34.6%), antileukotrienes (22.6%), topical nasal corticosteroids (20.3%), and inhaled corticosteroids (17.7%). From all prescriptions, 422 (34.5%) were considered off-label for age (62.6%), dosage (31.7%), or clinical indication (5.7%). Off-label use was more frequent in children aged <2 years, with 73.5% prescribed for children of this age. CONCLUSIONS: Off-label use of drugs for the treatment of paediatric allergic diseases is high. However, these prescriptions are not necessarily wrong, and are recommended in many guidelines. Randomised controlled studies are limited by methodological difficulties creating the need for more observational studies in order to further evaluate the safety and efficacy of drugs used in children

Épidémiologie de l’Asthme dans les Pays Lusophones

Asthma in schoolchildren became a priority both for developing and developed countries. Two large multi-centre epidemiological studies(Portuguese Study of Allergic Diseases in Childhood and the International Study of Asthma and Allergies in Childhood) were implemented in the last decade. One of the main objectives was to compare prevalence of asthma and evaluate cultural, ethnic and environmental variables in schoolchildren of different continents. These studies can contribute to a global strategy (with national specificity’s) including self management programs in the control of asthma to reduce the morbidity and mortality, and promote better quality of life with better allocation of resources

Epidemiologia da Asma Grave

A asma brônquica associa-se a apreciáveis taxas de morbilidade, traduzindo-se por um elevado número de recursos ao serviço de urgência e internamentos hospitalares. Apesar de uma tendência decrescente observada nas últimas décadas nas taxas de mortalidade associadas a esta doença, verifica-se ainda um número significativo de óbitos evitáveis por asma. Os autores apresentam os dados nacionais relativos aos óbitos por asma (dados fornecidos pelo Instituto Nacional de Estatística) e aos internamentos hospitalares por asma (dados fornecidos pelo Instituto de Gestão Informática e Financeira do Ministério da Saúde - Grupos de Diagnósticos Homogéneos: diagnósticos de saída), durante a última década, avaliando também estes dados por sexo, grupo etário e local de residência. Realça-se a importância do diagnóstico e tratamento precoces da asma, prevenindo formas graves e perspectivando a optimização da qualidade de vida e controlo da doença

Off-label prescribing for allergic diseases in children

The majority of drugs prescribed have not been tested in children and safety and efficacy of children's medicines are frequently supported by low quality of evidence. Therefore, a large percentage of prescriptions for children in the clinical daily practice are used off label. Despite the several recent legislation and regulatory efforts performed worldwide, they have not been successful in increasing availability of medicines adapted to children. Moreover, if we consider that 30% of the prescribed drugs for children are for the respiratory field and only 4% of new investigation projects for children research were proposed to access drugs for respiratory and allergy treatment, there is a clear imbalance of the children needs in this therapeutic area. This narrative review aimed to describe and discuss the off-label use of medicines in the treatment and control of respiratory and allergic diseases in children. It was recognized that a large percentage of prescriptions performed for allergy treatment in daily clinical practice are off label. The clinicians struggle on a daily basis with the responsibility to balance risk-benefits of an off-label prescription while involving the patients and their families in this decision. It is crucial to increase awareness of this reality not only for the clinician, but also to the global organizations and competent authorities. New measures for surveillance of off-label use should be established, namely through population databases implementation. There is a need for new proposal to correct the inconsistency between the priorities for pediatric drug research, frequently dependent on commercial motivations, in order to comply to the true needs of the children, especially on the respiratory and allergy fields

Asthma costs and social impact

In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle risk factors. In many countries noncommunicable diseases, like asthma, are not yet considered a healthcare priority. This review will analyze and discuss disparities in asthma management in several countries and regions, such as access to healthcare human resources and medications, due to limited financial capacity to develop strategies to control and prevent this chronic disease. This review tries to explore the social and economic burden of asthma impact on society. Although asthma is generally accepted as a costly illness, the total costs to society (direct, indirect and intangible asthma costs) are difficult to estimate, mainly due to different disease definitions and characterizations but also to the use of different methodologies to assess the asthma socio-economic impact in different societies. The asthma costs are very variables from country to country, however we can estimate that a mean cost per patient per year, including all asthmatics (intermittent, mild, moderate and severe asthma) in Europe is $USD 1,900, which seems lower than USA, estimated mean$USD 3,100.info:eu-repo/semantics/publishedVersio